TMS to Improve Recovery Outcomes Among Patients With Opioid Use Disorder (OUD) and Alcohol Use Disorder (AUD)

Part of paid clinical trials in Portland, Oregon.

Sponsor
Washington State University
Study ID
NCT07171359
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • TMS Low-Dose — DEVICE
    one 3-minute session of TMS TBS delivered each morning, prior to commencement of their regularly scheduled daily therapy activities, for 5 days/week, for a total of four-weeks (20 sessions total).
  • TMS High-Dose — DEVICE
    One 9-minute session of TMS TBS delivered each morning, prior to commencement of their regularly scheduled daily therapy activities, for 5 days/week, for a total of four-weeks (20 sessions total).

Study Details

The study aims to explore the potential of Transcranial Magnetic Stimulation (TMS), particularly Theta Burst Stimulation (TBS), as an adjunctive treatment to enhance recovery outcomes (consumption and craving; withdrawal symptoms; mental, physical, sleep, and cognitive health; engagement with therapy, etc.) in individuals with Opioid Use Disorder (OUD) and individuals with Alcohol Use Disorder (AUD). This project will be completed in partnership with Another Chance Rehab (Portland): Portland's top addiction treatment program offering evidence-based treatment programs for a range of substance use disorders. Another Chance Rehab will serve as the project site for this work.

Key Dates

Start date
Jun 1, 2027
Status verified
May 2026
Primary completion
Jun 30, 2027
Completion
Oct 1, 2027

Study Design

Enrollment
60 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • No Intervention: Treatment As Usual
    Study participants in this arm will engage in intensive outpatient alcohol and addiction treatment provided as it usually is for all patients in this program.
  • Active Comparator: 3-Minute TMS
    TAU + 3-minute TMS: Participants complete TAU as described above, with one 3-minute session of TMS TBS delivered each morning, prior to commencement of their regularly scheduled daily therapy activities, for 5 days/week, for a total of four-weeks (20 sessions total).
  • Active Comparator: 9-Minute TMS
    TAU + 9-minute TMS: Participants complete TAU as described above, with one 9-minute session of TMS TBS delivered each morning, prior to commencement of their regularly scheduled daily therapy activities, for 5 days/week, for a total of four-weeks (20 sessions total).

Primary Outcome Measure

Engagement in Treatment As Usual activities [ Time Frame: 4 weeks ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Another Chance Drug & Alcohol Rehab Center of PortlandPortlandOregon97232
John Morgan, CADC II, QMHA
[email protected]
503-995-3718
Benjamin Schwartz, MD
[email protected]
503-997-3543
Benjamin Schwartz, MD (SUB_INVESTIGATOR)

Find similar trials in Portland, OR

By condition
Substance use disorder
By specialty
Behavioral healthAddiction medicine
By research site
Another Chance Drug & Alcohol Rehab Center of Portland· Portland, OR

Related Studies